The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Communications and UpdatesFull Access

Celiac Disease and Schizophrenia

To the Editor: In the June issue, Karlsson et al. (1) report an association between high levels of antigliadin immunoglobulin (Ig) G in maternal circulation and elevated risk of nonaffective psychosis in offspring. The authors propose several possible mechanisms to explain this association, and I wish to suggest an alternative explanation. Because gliadin must cross the intestinal epithelium to evoke IgG antigliadin antibodies, greater intestinal permeability, both paracellular and transcellular, has been hypothesized as an early event in the development of celiac disease (2). Estrogens are described as playing a key role in the development and maintenance of the intestinal barrier (3). Bisphenol-A (BPA), an estrogenic endocrine disruptor, can prematurely and permanently close the barrier in perinatally exposed female but not male rats (3). As some degree of permeability is required for maturation of the immune system through the development of tolerance, the perinatally BPA-exposed female rat, lacking immunological tolerance, develops enhanced colonic inflammatory responses in adulthood (3). This would set the stage so that when the perinatally BPA-exposed female rat becomes pregnant, the pregnancy may be marked by enhanced inflammation. Paradoxically, estrogenic exposure may have anti-inflammatory effects in the exposed adult, but inappropriate estrogen exposure may have pro-inflammatory effects in the perinatally exposed offspring. These effects were observed at levels of BPA exposure previously believed to be too low for observed adverse effects in humans (3).

I have proposed elsewhere an estrogenic endocrine disruption theory of schizophrenia, in which inappropriate dosage, timing, or duration of prenatal estrogen exposure causes schizophrenia (4, 5). Within this theoretical framework, inappropriate estrogen exposure occurring in the brain could also be occurring in the colon so that an association of celiac disease or some other inflammation and schizophrenia may be observable not from a genetic link per se but rather a transgenerational effect of prenatal estrogen exposure.

Richmond, Va.

The author reports no financial relationships with commercial interests.

References

1 Karlsson H, Blomström A, Wicks S, Yang S, Yolken RH, Dalman C: Maternal antibodies to dietary antigens and risk for nonaffective psychosis in offspring. Am J Psychiatry 2012; 169:625–632LinkGoogle Scholar

2 Rubio-Tapia A, Murray JA: Celiac disease. Curr Opin Gastroenterol 2010; 26:116–122Crossref, MedlineGoogle Scholar

3 Braniste V, Jouault A, Gaultier E, Polizzi A, Buisson-Brenac C, Leveque M, Martin PG, Theodorou V, Fioramonti J, Houdeau E: Impact of oral bisphenol A at reference doses on intestinal barrier function and sex differences after perinatal exposure in rats. Proc Natl Acad Sci USA 2010; 107:448–453Crossref, MedlineGoogle Scholar

4 Brown JS: Association of increased prenatal estrogen with risk factors for schizophrenia. Schizophr Bull 2011; 37:946–949Crossref, MedlineGoogle Scholar

5 Brown JS: Effects of bisphenol-A and other endocrine disruptors compared with abnormalities of schizophrenia: an endocrine-disruption theory of schizophrenia. Schizophr Bull 2009; 35:256–278Crossref, MedlineGoogle Scholar